If a cancer patient is fortuitously found (by the map) to be pre-diabetic, then certain cancer treatments (e.g., inhibiting PI3K) could be dangerous, because the treatments could induce severe metabolic toxicity, such as hyperglycemia. The gene discussed is PIK3CA; the disease is Hyperglycemia.